Language:
Currency:
VAT Mode:
  • USA Head Lice Treatment
  • Canada Head Lice Treatment
  • UK Head Lice Treatment
  • Ireland Head Lice Treatment
  • Netherlands Head Lice Treatment
  • Hungary Head Lice Treatment
  • Puerto Rico Head Lice Treatment
  • Germany Head Lice Treatment
  • France Head Lice Treatment
  • Spain Head Lice Treatment
  • Portugal Head Lice Treatment
  • Chile Head Lice Treatment

Management Team

Larada Sciences has assembled a proven scientific and operating team that is uniquely qualified to lead the commercialization and global adoption of this breakthrough technology. The Company was founded by serial entrepreneurs with numerous successful start-ups and a detailed understanding of medical device markets and their dynamics. Together, the founders and key personnel represent a focused and capable group who have developed and commercialized more than 50 medical products in both start-ups and large companies.

Larry D. Rigby is currently founder, Chairman and CEO of Larada Sciences, a University of Utah spinout. He was co-founder and Chief Executive Officer of ZARS Pharma from inception in 1996 to January 2006. He is currently Vice Chairman of ZARS. Mr. Rigby started his medical career with Sorenson Research Company in August 1975 where he was Vice President of Sales and Marketing. From August 1982 to August 1985, he was President of Martin U.S.A., a subsidiary of the German company Gebrűder Martin.

From August 1985 to June 1995 he was Chairman and founder of Alton Dean Medical, which was acquired by Mallinckrodt Medical in June 1995. In August 1986 he founded and became Chief Executive Officer of CardioPulmonics, which went public in 1992 and later merged with Innerdyne and then again with Tyco. Mr. Rigby was recently President of MicroJect, a company he founded in 1993 and which was acquired in 1998 by Sorenson Development. He is a co-founder and former Director of Kalypto Medical, co-founder and Chairman of Aplion Medical, and current Chairman of VisualShare, Inc. He serves as Chairman of Exeven Therapeutics, a University of Utah spinout that he cofounded. He is co-founder of The Salt Lake Life Science Angels.

Mr. Rigby has a B.A. from Idaho State University, an M.A. from the University of Kansas and further graduate work at The Johns Hopkins University. Idaho State University honored him in 2006 with its Distinguished Alumni Award.

Mr. Randall D. Block is a founder, Director, and President and COO of Larada Sciences. He previously founded three successful technology-based start-ups and has over 15 years of experience commercializing emerging technologies and medical products. As a business leader and biomedical engineer, he has been responsible for the successful development of nearly 20 commercial products that have collectively surpassed $100M in revenues, and his innovations have been awarded eight US patents and several national awards.

Mr. David Rudd, J.D., is a founder and advisor to Larada. Mr. Rudd is a partner with Ballard Spahr Andrews & Ingersoll (SLC, UT) where he practices law in the area of complex domestic and international business transactions. He regularly advises clients on general business matters, mergers, acquisitions, joint ventures, alternative market entry strategies and structures, private and public equity and debt financings, securities, and distribution, agency, and licensing matters. He has been a founder and director for several successful technology and medical technology start-ups.

Marleen De Winter., Director of Marketing, has extensive international experience in marketing, PR, account management and sales, working for global companies such as Allied International and Marsh Inc. in Brussels, Belgium, and most recently at Microsoft Corporation, creating best practices across various teams. She graduated with a Law Degree and a Postgraduate Degree in International Relations from the KUL in Belgium.